Novastan: Began second Phase III trial in 300 patients, primarily in Canada. The trial will compare the direct thrombin inhibitor with ancrod, an anti-thromboti

Texas Biotechnology Corp. (TXB), Houston Product: Novastan, argatroban injection Indication: Prophylactic for heparin-induced thrombocytopenia, and treatment for heparin-induced thrombocytopenia and...